Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

62 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
The multi-biomarker disease activity score tracks response to rituximab treatment in rheumatoid arthritis patients: a post hoc analysis of three cohort studies.
Roodenrijs NMT, de Hair MJH, Wheater G, Elshahaly M, Tekstra J, Teng YKO, Lafeber FPJG, Hwang CC, Liu X, Sasso EH, van Laar JM. Roodenrijs NMT, et al. Among authors: tekstra j. Arthritis Res Ther. 2018 Nov 20;20(1):256. doi: 10.1186/s13075-018-1750-5. Arthritis Res Ther. 2018. PMID: 30458871 Free PMC article.
Effect on Costs and Quality-adjusted Life-years of Treat-to-target Treatment Strategies Initiating Methotrexate, or Tocilizumab, or Their Combination in Early Rheumatoid Arthritis.
Verhoeven MMA, Tekstra J, van Laar JM, Pethö-Schramm A, Borm MEA, Bijlsma JWJ, Jacobs JWG, Lafeber FPJG, Welsing PMJ. Verhoeven MMA, et al. Among authors: tekstra j. J Rheumatol. 2021 Apr;48(4):495-503. doi: 10.3899/jrheum.200067. Epub 2020 Aug 1. J Rheumatol. 2021. PMID: 32739893
The multi-biomarker disease activity test for assessing response to treatment strategies using methotrexate with or without prednisone in the CAMERA-II trial.
Jurgens MS, Safy-Khan M, de Hair MJH, Bijlsma JWJ, Welsing PMJ, Tekstra J, Lafeber FPJG, Sasso EH, Jacobs JWG; Society for Rheumatology research Utrecht. Jurgens MS, et al. Among authors: tekstra j. Arthritis Res Ther. 2020 Sep 9;22(1):205. doi: 10.1186/s13075-020-02293-x. Arthritis Res Ther. 2020. PMID: 32907614 Free PMC article. Clinical Trial.
Efficacy of Tocilizumab Monotherapy Versus Tocilizumab and Methotrexate Combination Therapy in the Prevention of Radiographic Progression in Rheumatoid Arthritis: An Analysis Using Individual Patient Data From Multiple Clinical Trials.
Verhoeven MMA, Tekstra J, Jacobs JWG, Bijlsma JWJ, van Laar JM, Pethö-Schramm A, Borm MEA, Lafeber FPJ, Welsing PMJ. Verhoeven MMA, et al. Among authors: tekstra j. Arthritis Care Res (Hoboken). 2022 Jun;74(6):889-895. doi: 10.1002/acr.24524. Epub 2022 Mar 25. Arthritis Care Res (Hoboken). 2022. PMID: 33253497 Free PMC article.
Development and Validation of Rheumatoid Arthritis Disease Activity Indices Including HandScan (Optical Spectral Transmission) Scores.
Verhoeven MMA, Westgeest AAA, Schwarting A, Jacobs JWG, Heller C, van Laar JM, Lafeber FPJG, Tekstra J, Triantafyllias K, Welsing PMJ. Verhoeven MMA, et al. Among authors: tekstra j. Arthritis Care Res (Hoboken). 2022 Sep;74(9):1493-1499. doi: 10.1002/acr.24607. Epub 2022 Jun 18. Arthritis Care Res (Hoboken). 2022. PMID: 33770421 Free PMC article.
Using real-world data to dynamically predict flares during tapering of biological DMARDs in rheumatoid arthritis: development, validation, and potential impact of prediction-aided decisions.
van der Leeuw MS, Messelink MA, Tekstra J, Medina O, van Laar JM, Haitjema S, Lafeber F, Veris-van Dieren JJ, van der Goes MC, den Broeder AA, Welsing PMJ. van der Leeuw MS, et al. Among authors: tekstra j. Arthritis Res Ther. 2022 Mar 23;24(1):74. doi: 10.1186/s13075-022-02751-8. Arthritis Res Ther. 2022. PMID: 35321739 Free PMC article.
62 results